DAXX and cancer: By binding with SUMOylated-SMAD4, DAXX inhibits the tumor suppressive effect of transforming growth factor-β (TGF-β) signaling mediated by SMAD4 (Chang et al., 2005), which affects the growth arrest and apoptosis of cancer cells (Zhao et al., 2018).